Who owns Crescent Biopharma Inc?
- Ticker: CBIO
- CUSIP Number: g2545c104
Tip: Access positions for across all investors
Analyze quarterly positions in Crescent Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Crescent Biopharma stock
Who bought or sold Crescent Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 4.1M | $76M | 0% | Mar 2026 |
|
| BVF | 2.7M | $51M | 0% | Mar 2026 |
|
| Fairmount Funds Management | 2.7M | $51M | 0% | Mar 2026 |
|
| VR Adviser | 2.1M | $39M | 0% | Mar 2026 |
|
| Fcpm Iii Services B.v. | 1.7M | $31M | 0% | Mar 2026 |
|
| Balyasny Asset Management | 1.5M | $28M | 1252% | Mar 2026 |
|
| Vestal Point Capital | 1.5M | $28M | 0% | Mar 2026 |
|
| Opaleye Management | 1.3M | $24M | 11% | Mar 2026 |
|
| Tang Capital Management | 1.2M | $21M | 33% | Mar 2026 |
|
| Vanguard Capital Management | 801k | $15M | 100% | Mar 2026 |
|
| Logos Global Management | 483k | $8.9M | -20% | Mar 2026 |
|
| Deep Track Capital | 454k | $8.3M | 0% | Mar 2026 |
|
| Rtw Investments | 373k | $6.8M | 0% | Mar 2026 |
|
| Millennium Management | 324k | $5.9M | 423% | Mar 2026 |
|
| Point72 Asset Management | 300k | $5.5M | 0% | Mar 2026 |
|
| Alyeska Investment Group | 264k | $4.8M | 0% | Mar 2026 |
|
| Goldman Sachs Group | 229k | $4.2M | 805% | Mar 2026 |
|
| Susquehanna International | 214k | $3.9M | 274% | Mar 2026 |
|
| Perceptive Advisors | 207k | $3.8M | -54% | Mar 2026 |
|
| Marshall Wace | 201k | $3.7M | 820% | Mar 2026 |
|
| Exome Asset Management | 153k | $2.8M | 100% | Mar 2026 |
|
| Jennison Associates | 153k | $2.8M | 100% | Mar 2026 |
|
| Silverarc Capital Management | 131k | $2.4M | 100% | Mar 2026 |
|
| Two Sigma Investments | 116k | $2.1M | -8% | Mar 2026 |
|
| BlackRock | 116k | $2.1M | 6% | Mar 2026 |
|
| Geode Capital Management | 104k | $1.9M | 14% | Mar 2026 |
|
| Hudson Bay Capital Management | 89k | $1.6M | 100% | Mar 2026 |
|
| Stonepine Capital Management | 85k | $1.6M | -3% | Mar 2026 |
|
| UBS Group | 83k | $1.5M | 1061% | Mar 2026 |
|
| Burkehill Global Management | 74k | $1.4M | 0% | Mar 2026 |
|
| Woodline Partners | 74k | $1.4M | 0% | Mar 2026 |
|
| ADAR1 Capital Management | 50k | $924k | -92% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 49k | $908k | 100% | Mar 2026 |
|
| State Street Corporation | 39k | $718k | 49% | Mar 2026 |
|
| Barclays | 30k | $555k | 100% | Mar 2026 |
|
| Bank of America Corporation | 29k | $538k | 100% | Mar 2026 |
|
| Moore Capital Management | 25k | $459k | 0% | Mar 2026 |
|
| Lighthouse Investment Partners | 25k | $459k | 100% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 25k | $458k | 0% | Mar 2026 |
|
| Renaissance Technologies | 24k | $446k | -48% | Mar 2026 |
|
| Citigroup | 20k | $371k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 20k | $359k | 100% | Mar 2026 |
|
| Morgan Stanley | 19k | $341k | -32% | Mar 2026 |
|
| OMERS Administration Corporation | 18k | $327k | 53% | Mar 2026 |
|
| Northern Trust | 17k | $317k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 16k | $288k | 338% | Mar 2026 |
|
| Algert Coldiron Investors | 14k | $254k | 100% | Mar 2026 |
|
| Verdad Advisers | 13k | $234k | 100% | Mar 2026 |
|
| Cannon Global Investment Management | 10k | $187k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 3.5k | $64k | 100% | Mar 2026 |
|
| Parallel Advisors | 264.00 | $4.8k | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 161.00 | $3.0k | 100% | Mar 2026 |
|
| SBI Securities | 68.00 | $1.2k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 51.00 | $0 | 100% | Mar 2026 |
|
| Fortitude Family Office | 40.00 | $735.000000 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 26.00 | $477.001200 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 4.00 | $73.000000 | 100% | Mar 2026 |
|
Who sold out of Crescent Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boxer Capital Management | Dec 2025 | 454k | $5.4M |
| Driehaus Capital Management | Dec 2025 | 303k | $3.6M |
| Heights Capital Management | Dec 2025 | 264k | $3.1M |
| Wellington Management Company | Dec 2025 | 143k | $1.6M |
| Blackstone Group | Dec 2025 | 76k | $897k |
| Leucadia National Corporation | Dec 2025 | 64k | $762k |
| Two Sigma Advisers | Dec 2025 | 33k | $386k |
| Jane Street | Dec 2025 | 23k | $272k |
| Hrt Financial | Dec 2025 | 13k | $155k |
| Tower Research Capital | Dec 2025 | 409.00 | $4.9k |
| Efficient Wealth Management | Dec 2025 | 40.00 | $0 |
| Group One Trading | Dec 2025 | 4.00 | $47.000000 |